Topic: How To Invest

Q: Hi, all. May I have TSI’s opinion on Stryker Corp.?

Article Excerpt

A: Stryker Corporation, $206.97, symbol SYK on New York (Shares outstanding: 373.1 million; Market cap: $76.8 billion; www.stryker.com), is one of the world’s leading medical technology companies. The firm is based in Kalamazoo, Michigan. Stryker’s investors benefit from its three business segments: The Orthopaedics segment (37% of total revenue) sells products used in joint replacement surgeries and in trauma and extremities surgeries. The Medical and Surgery segment (44%) sells surgical equipment and navigation instruments, endoscopic and communications systems, and devices used in a variety of medical specialties. The Neurotechnology and Spine segment (19%) sells neurosurgical, neurovascular, and spinal implant devices. Approximately 72% of Stryker’s revenue has been earned in the U.S. in each of the past 3 years. The company has been actively acquiring firms, all of which have developed innovative products and services in the medical industry: In February 2019, Stryker purchased Arrinex, Inc., a medical-devices manufacturer headquartered in Menlo Park, California, for an undisclosed amount. Arrinex owns ClariFix, a cryoablation technology for the treatment of chronic rhinitis…

You are trying to access subscriber-only content.

To read this article, you may subscribe or sign in.
If you are already a subscriber, log in here.

If you wish to become a subscriber, click here. Or you may enjoy access to all our publications when you become a Member of Pat McKeough's Inner Circle Pro.